-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Mural Oncology, Lowers Price Target to $6

Benzinga·03/26/2025 10:50:22
Listen to the news
HC Wainwright & Co. analyst Andres Maldonado maintains Mural Oncology (NASDAQ:MURA) with a Buy and lowers the price target from $18 to $6.